Alexion Pharmaceuticals, Inc. (ALXN) CEO Ludwig Hantson on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 07/24/19
Pharma Giant Tops Estimates And Predicts Smaller Dip In 2019 ProfitInvestors Business Daily • 07/24/19
Alexion Pharmaceuticals (ALXN) Surpasses Q2 Earnings and Revenue EstimatesZacks Investment Research • 07/24/19
Is Alexion (ALXN) a Solid Growth Stock? 3 Reasons to Think " Yes "Zacks Investment Research • 07/18/19
Biotech Stock Roundup: Amgen Gets FDA Nod for Kanjinti, Regeneron Presents DataZacks Investment Research • 06/19/19
Software Stocks Most Overvalued Among Tech Issues, Says Goldman SachsInvestors Business Daily • 06/17/19